Structural Chemistry

, Volume 28, Issue 3, pp 567–576 | Cite as

Structural analysis and antitumor potential of novel 5,6-disubstituted-17a-homo-17-oxa-androstane derivatives

  • Ivana Kuzminac
  • Olivera R. Klisurić
  • Dušan Škorić
  • Dimitar Jakimov
  • Marija Sakač
Original Research


Starting from 3β-acetoxy-17a-homo-17-oxa-androst-5-en-16-one (1) and in the reaction with N-bromoacetamide (NBA) and perchloric acid, the 5α-bromo-6β-hydroxy (2), 5β,6β-epoxy (3) and 5α,6β-dibromo (4) derivatives were obtained. The structure of compounds 24, particularly stereochemistry at C5 and C6, is established by detailed NMR and X-ray analysis. The in vitro antiproliferative activity of newly synthesized compounds 2–4 against six human tumor cell lines was evaluated. All three compounds showed a significant toxicity toward hormone-independent breast adenocarcinoma MDA-MB-231 and cervical carcinoma cells HeLa, while dibromo derivative 4 was active toward five human cancer cell lines. These new 5,6-disubstituted-D-homolactone steroidal compounds have also displayed selectivity toward cancerous cell lines against inactivity found for noncancerous control cell line. This selectivity was not found for control compound, well-known chemotherapy drug cisplatin.


D-homoandrostane lactone Halogen derivatives NMR studies X-ray structural analysis Antiproliferative activity 



We thank the Ministry of Education, Science and Technological Development of the Republic of Serbia for financial support (Grant No. 172021).

Supplementary material

11224_2016_815_MOESM1_ESM.pdf (627 kb)
Supplementary material 1 (PDF 626 kb)


  1. 1.
  2. 2.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) CA Cancer J Clin 61:69–90CrossRefGoogle Scholar
  3. 3.
    Gupta A, Kumar BS, Negi AS (2013) J Steroid Biochem Mol Biol 137:242–270CrossRefGoogle Scholar
  4. 4.
    Cocconi G (1994) Breast Cancer Res Treat 30:57–80CrossRefGoogle Scholar
  5. 5.
    Djurendić EA, Sakač MN, Zaviš MP, Gaković AR, Čanadi JJ, Andrić SA, Klisurić OR, Kojić VV, Bogdanović GM, Penov Gaši KM (2008) Steroids 73:681–688CrossRefGoogle Scholar
  6. 6.
    Djurendić EA, Zaviš MP, Sakač MN, Čanadi JJ, Kojić VV, Bogdanović GM, Penov Gaši KM (2009) Steroids 74:983–988CrossRefGoogle Scholar
  7. 7.
    Djurendić EA, Savić MP, Klisurić OR, Sakač MN, Bogdanović GM, Jakimov DS, Penov Gaši KM (2012) Struct Chem 23:1761–1767CrossRefGoogle Scholar
  8. 8.
    Savić MP, Djurendić EA, Petri ET, Ćelić A, Klisurić OR, Sakač MN, Jakimov DS, Kojić VV, Penov Gaši KM (2013) RSC Adv 3:10385–10395CrossRefGoogle Scholar
  9. 9.
    Balunas MJ, Su B, Riswan S, Fong HHS, Brueggemeier RW, Pezzuto JM, Kinghorn AD (2009) Phytochem Lett 2:29–33CrossRefGoogle Scholar
  10. 10.
    Hayakawa Y, Furihata K, Shinya K, Mori T (2003) Tetrahedron Lett 44:1165–1166CrossRefGoogle Scholar
  11. 11.
    Dembitsky VM (2008) Eur J Med Chem 43:223–251CrossRefGoogle Scholar
  12. 12.
    Ivanchina NV, Kicha AA, Stonik VA (2011) Steroids 76:425–454CrossRefGoogle Scholar
  13. 13.
    Liu TF, Lu X, Tang H, Zhang MM, Wang P, Sun P, Liu ZY, Wang ZL, Li L, Rui YC, Li TJ, Zhang W (2013) Steroids 78:108–114CrossRefGoogle Scholar
  14. 14.
    Carvalho JFS, Silva MMC, Moreira JN, Simoes S, Melo MLS (2010) J Med Chem 53:7632–7638CrossRefGoogle Scholar
  15. 15.
    Numazawa M, Handa W, Hasegawa C, Takahashi M (2005) J Steroid Biochem Mol Biol 97:353–359CrossRefGoogle Scholar
  16. 16.
    Llanos GGL, Araujo LM, Jiménez IA, Moujir LM, Bazzocchi IL (2012) Eur J Med Chem 54:499–511CrossRefGoogle Scholar
  17. 17.
    Möller G, Deluca D, Gege C, Rosinus A, Kowalik D, Peters O, Droescher P, Elger W, Adamski J, Hillisch A (2009) Bioorg Med Chem Lett 19:6740–6744CrossRefGoogle Scholar
  18. 18.
    Diffraction Oxford (2009) CrysAlis CCD and CrysAlis Red. Oxford Diffraction, AbingdonGoogle Scholar
  19. 19.
    Blessing RH (1995) Acta Crystalogr A51:33–38CrossRefGoogle Scholar
  20. 20.
    Clark RC, Reid JS (1995) Acta Crystalogr A51:887–897CrossRefGoogle Scholar
  21. 21.
    Sheldrick GM (2015) Acta Crystallogr A 71:3–8CrossRefGoogle Scholar
  22. 22.
    Farrugia LJ (1997) J Appl Crystallogr 30:565CrossRefGoogle Scholar
  23. 23.
    Bruno IJ, Cole JC, Edgington PR, Kessler MK, Macrae CF, McCabe P, Pearson J, Taylor R (2002) Acta Crystallogr B 58:389–397CrossRefGoogle Scholar
  24. 24.
    Farrugia LJ (1999) J Appl Crystallogr 32:837–838CrossRefGoogle Scholar
  25. 25.
    Flack HD (1983) Acta Crystallogr A 39:876–881CrossRefGoogle Scholar
  26. 26.
    Mosmann T (1983) J Immunol Methods 65:55–63CrossRefGoogle Scholar
  27. 27.
    Grenville V, Patel DK, Petrow V, Stuart-Webb IA, Williamson DM (1957) J Chem Soc 1:4105–4111CrossRefGoogle Scholar
  28. 28.
    Bowers A, Denot E, Cuellar Ibanez L, Cabezas EM, Ringold HJ (1962) J Org Chem 27:1862–1867CrossRefGoogle Scholar
  29. 29.
    Numazawa M, Yamada K (1999) Steroids 64:320–327CrossRefGoogle Scholar
  30. 30.
    Cremer D, Pople JA (1975) J Am Chem Soc 97:1354–1358CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Department of Chemistry, Biochemistry and Environmental Protection, Faculty of SciencesUniversity of Novi SadNovi SadSerbia
  2. 2.Department of Physics, Faculty of SciencesUniversity of Novi SadNovi SadSerbia
  3. 3.Oncology Institute of VojvodinaSremska KamenicaSerbia

Personalised recommendations